Edaravone | CAS:89-25-8 99.0% bulk supply

We serve Edaravone CAS:89-25-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Chemical Name: Edaravone

CAS.NO:89-25-8

Synonyms:1-PHENYL-3-METHYL-5-OXO-2-PYRAZOLINE;3-methyl-1-phenyl-1H-pyrazol-5(4H)-one;1-PHENYL-3-METHYL-5-PYRAZALONE;3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE FOR SYNTHESIS;Edaravone (MCI-186)

Molecular Formula:C10H10N2O

Molecular Weight:174.19900

Physical and Chemical Properties:

Density:1,12 g/cm3

Boiling point:287 °C265 mm Hg(lit.)

Melting point:126-128 °C(lit.)

Flash point:191°C/17mm

Index of Refraction:1.606

Specification:

Appearance:Light yellow crystalline powder

Purity:≥99.0%

Packing: 25kg drum

Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Store protected from light.

Application:Mainly used for organic synthesis C.I. Pigment Yellow 60; C.I. Pigment Orange 13; 50; C. I. Pigment Red 41; C. I. Acid Orange 74; 89; C. I. Acid Red 226 and C.I. Pigment Brown 50 and other varieties of coupling components.

Contact us for information like edaravone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Edaravone (MCI-186) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-PHENYL-3-METHYL-5-OXO-2-PYRAZOLINE Use and application,3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE FOR SYNTHESIS technical grade,usp/ep/jp grade.

Related News: The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.D-Phenylglycine manufacturer Others — somewhat more cynically — wondered if this was a concerted effort to promote certain herbal products to boost their makers’ share prices ahead of the Chinese stock market’s re-opening Monday.propan-2-yl (2S)-2-[[(2,3,4,5,6-pentafluorophenoxy)-phenoxyphosphoryl]amino]propanoate supplier Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.4'-Chloro-2'-Fluoroacetophenone vendor The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.